SEC Filings TLDR Banner

Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.

Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.

Filter by Form Type:
All346-K8-K10-Q144Schedule 13GSchedule 13G/ASchedule 13DSchedule 13D/A
Industry:Biotechnologyβœ•
Previous Page56789101112Next Page
2026-09-16HEPA3Form 3 Filing for Hepion Pharmaceuticals, Inc.HIGH
This filing reports initial beneficial ownership of securities for KI Holdings, Ltd., a significant owner of Hepion Pharmaceuticals, Inc. (HEPA). The filing details 10,000,000 shares of Common Stock held indirectly. Additionally, it discloses 10,000,000 warrants to purchase Common Stock, with an exercise price of $0.06...
Biotechnology
2026-09-16INMB3Form 3 Initial Beneficial Ownership Statement Filed by New Director James Sapirstein of Inmune Bio, Inc.
This is a Form 3 - Initial Statement of Beneficial Ownership of Securities filed by James Sapirstein with the SEC in connection with his appointment as a director of Inmune Bio, Inc. (ticker: INMB), a biotechnology company headquartered in Boca Raton, Florida. The filing covers the period of report ending September 8, ...
Micro CapBiotechnology
2026-09-16Hepion Pharmaceuticals, Inc.3Form 3 Filing for Hepion Pharmaceuticals, Inc.DuplicateHIGH
This filing reports initial beneficial ownership of securities for KI Holdings, Ltd., a significant owner of Hepion Pharmaceuticals, Inc. (HEPA). The filing details 10,000,000 shares of Common Stock held indirectly. Additionally, it discloses 10,000,000 warrants to purchase Common Stock, with an exercise price of $0.06...
Biotechnology
2026-09-16LEGN3Power of Attorney for Ingrid ZhangMEDIUM
This filing is an Exhibit 24, a Power of Attorney, for Ingrid Zhang, Chief Executive Officer of Legend Biotech Corp. The document, dated September 10, 2026, grants power of attorney to Robert Staloff of Legend Biotech Corp. to execute and file Forms 3, 4, and 5 with the SEC on behalf of Ms. Zhang. This authorization is...
Mid CapBiotechnology
2026-09-16Inmune Bio, Inc.3Form 3 Initial Beneficial Ownership Statement Filed by New Director James Sapirstein of Inmune Bio, Inc.Duplicate
This is a Form 3 - Initial Statement of Beneficial Ownership of Securities filed by James Sapirstein with the SEC in connection with his appointment as a director of Inmune Bio, Inc. (ticker: INMB), a biotechnology company headquartered in Boca Raton, Florida. The filing covers the period of report ending September 8, ...
Micro CapBiotechnology
2026-09-16Legend Biotech Corp3Power of Attorney for Ingrid ZhangDuplicateMEDIUM
This filing is an Exhibit 24, a Power of Attorney, for Ingrid Zhang, Chief Executive Officer of Legend Biotech Corp. The document, dated September 10, 2026, grants power of attorney to Robert Staloff of Legend Biotech Corp. to execute and file Forms 3, 4, and 5 with the SEC on behalf of Ms. Zhang. This authorization is...
Mid CapBiotechnology
Previous Page56789101112Next Page